Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Méndez AB"'
Publikováno v:
European Journal of Heart Failure; Feb2013, Vol. 15 Issue 2, p237-239, 3p
Publikováno v:
Scientia
Cardiorenal syndrome; Chronic renal failure; Diuretics Síndrome cardiorrenal; Insuficiencia renal crónica; Diuréticos Síndrome cardiorenal; Insuficiència renal crònica; Diürètics Cardiorenal syndrome (CRS) is a complex disease in which the he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2271b687ce71042f8dc359164e9776
https://doi.org/10.1093/ckj/sfac133
https://doi.org/10.1093/ckj/sfac133
Autor:
Giménez E; Grup de Recerca en Serveis Sanitaris, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, España; Sistemas de Información y Apoyo a la Decisión, Hospital Universitari Vall d'Hebron, Barcelona, España. Electronic address: enmanuel.gimenez@vallhebron.cat., Abadías MJ; Grup de Recerca en Serveis Sanitaris, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, España., San-José A; Servicio de Medicina Interna, Hospital Universitari Vall d'Hebron, Barcelona, España., Losada M; Enfermera, Área de Conocimiento de Alternativas a la Hospitalización, Servicio de Geriatría, Hospital Universitari Vall d'Hebron, Barcelona, España., Acezat J; Equipo de Atención Primaria de Casernes, Institut Català de la Salut, Barcelona, España., Ibáñez J; Hospital de Día, Medicina Interna, Departamento Asistencial, Hospital San Rafael, Barcelona, España., Marte L; Grup de Recerca en Serveis Sanitaris, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, España., Barrecheguren M; Servicio de Neumología, Hospital Universitari Vall d'Hebron, Barcelona, España., Méndez AB; Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Barcelona, España., Aguayo-Álvarez M; Grup de Recerca en Serveis Sanitaris, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, España; Departamento de Calidad, Procesos e Innovación, Vall d'Hebron Institut de Recerca, Barcelona, España., Arranz M; Servicio de Urgencias, Hospital Universitari Vall d'Hebron, Barcelona, España., Ramos R; Grup de Recerca en Serveis Sanitaris, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, España; Sistemas de Información y Apoyo a la Decisión, Hospital Universitari Vall d'Hebron, Barcelona, España.
Publikováno v:
Gaceta sanitaria [Gac Sanit] 2024 Nov 19; Vol. 38, pp. 102428. Date of Electronic Publication: 2024 Nov 19.
Autor:
Blandino G; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy. giovanni.blandino@ifo.it., Dinami R; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Marcia M; EMBL, Grenoble, France., Anastasiadou E; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy., Ryan BM; MiRNA Therapeutics, London, UK., Palcau AC; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Fattore L; SAFU Laboratory, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Regazzo G; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Sestito R; Preclinical models and new therapeutic agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Loria R; Unit of Cellular Networks and Molecular Therapeutic Targets, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Díaz Méndez AB; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Cappelletto MC; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Pulito C; Translational Oncology Research Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy., Monteonofrio L; Unit of Cellular Networks and Molecular Therapeutic Targets, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Calin GA; MDAnderson, University of Texas, Houston, USA., Sozzi G; IRCCS, National Cancer Institute, Milan, Italy., Cheong JK; National University of Singapore Yong Loo Lin School of Medicine, NUS Centre for Cancer Research and Mirxes Lab Pte Ltd, Singapore, Singapore., Aharonov R; Pangaea Biomed, Tel Aviv, Israel., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jul 29; Vol. 42 (1), pp. 189. Date of Electronic Publication: 2023 Jul 29.
Autor:
Díaz Méndez AB; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Sacconi A; Biostatistics and Bioinformatics Unit, Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Tremante E; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Lulli V; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Caprara V; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Rosanò L; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy., Goeman F; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Carosi M; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Giuliani M; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Vari G; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.; PhD Program in Molecular Medicine, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Silvani A; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Pollo B; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Garufi C; Medical-Oncology Unit, San Camillo Forlanini Hospital, Rome, Italy., Ramponi S; Medical-Oncology Unit, San Camillo Forlanini Hospital, Rome, Italy., Simonetti G; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Ciusani E; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Mandoj C; Clinical Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Scalera S; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Villani V; Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Po A; Department of Experimental Medicine, Sapienza University, Rome, Italy., Ferretti E; Department of Experimental Medicine, Sapienza University, Rome, Italy., Regazzo G; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. giulia.regazzo@ifo.it., Rizzo MG; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. maria.rizzo@ifo.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 17; Vol. 42 (1), pp. 66. Date of Electronic Publication: 2023 Mar 17.
Autor:
Olivella A; Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Barcelona 08035, Spain., Méndez AB; Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Barcelona 08035, Spain., Ferreira-González I; Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Barcelona 08035, Spain.
Publikováno v:
European heart journal [Eur Heart J] 2022 Jun 14; Vol. 43 (23), pp. 2247.
Autor:
Méndez AB; Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Azancot MA; Nephrology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Nephrology and Kidney Transplant Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Olivella A; Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Soler MJ; Nephrology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Nephrology and Kidney Transplant Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Publikováno v:
Clinical kidney journal [Clin Kidney J] 2022 May 06; Vol. 15 (10), pp. 1807-1815. Date of Electronic Publication: 2022 May 06 (Print Publication: 2022).
Autor:
Díaz Méndez AB; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Tremante E; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Regazzo G; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Brandner S; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK., Rizzo MG; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Publikováno v:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2021 Jun; Vol. 47 (4), pp. 471-487. Date of Electronic Publication: 2021 Jan 29.
Autor:
Regazzo G; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: giulia.regazzo@ifo.gov.it., Marchesi F; Department of Clinical and Experimental Oncology, Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: francesco.marchesi@ifo.gov.it., Spagnuolo M; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: manuela.spagnuolo@ifo.gov.it., Díaz Méndez AB; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: anabelen.diaz@ifo.gov.it., Masi S; Department of Research, Advanced Diagnostics and Technological Innovation, Clinical Pathology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: serena.masi@ifo.gov.it., Mengarelli A; Department of Clinical and Experimental Oncology, Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: andrea.mengarelli@ifo.gov.it., Rizzo MG; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, Rome, Italy. Electronic address: maria.rizzo@ifo.gov.it.
Publikováno v:
Blood reviews [Blood Rev] 2021 May; Vol. 47, pp. 100776. Date of Electronic Publication: 2020 Nov 10.
Autor:
Spagnuolo M; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Costantini M; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Ferriero M; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Varmi M; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Sperduti I; Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Regazzo G; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Cicchillitti L; Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Díaz Méndez AB; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Cigliana G; Department of Research, Advanced Diagnostics and Technological Innovation, Clinical Pathology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Pompeo V; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Russo A; Department of Research, Advanced Diagnostics and Technological Innovation, Pathology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Laquintana V; Department of Research, Advanced Diagnostics and Technological Innovation, Pathology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Mastroianni R; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Piaggio G; Department of Research, Advanced Diagnostics and Technological Innovation, SAFU Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Anceschi U; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Brassetti A; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Bove A; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Tuderti G; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Flammia RS; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy., Gallucci M; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy.; Department of Urology, 'Sapienza' University, Rome, Italy., Simone G; Department of Experimental Clinical Oncology, Urology Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144, Rome, Italy. giuseppe.simone@ifo.gov.it.; Department of Clinical and Experimental Oncology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. giuseppe.simone@ifo.gov.it., Rizzo MG; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. maria.rizzo@ifo.gov.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Apr 17; Vol. 39 (1), pp. 68. Date of Electronic Publication: 2020 Apr 17.